2023
Abstract C129: Impact of COVID-19 on colorectal cancer screening disparities: Results from a large commercially insured population in the United States
Siddique A, Wang R, Gaddy J, Gross C, Ma X. Abstract C129: Impact of COVID-19 on colorectal cancer screening disparities: Results from a large commercially insured population in the United States. Cancer Epidemiology Biomarkers & Prevention 2023, 32: c129-c129. DOI: 10.1158/1538-7755.disp23-c129.Peer-Reviewed Original ResearchBlue Cross Blue ShieldColorectal cancer screeningColorectal cancer screening disparitiesLow socioeconomic statusCancer screening disparitiesScreening ratesHigher socioeconomic statusSocioeconomic statusScreening disparitiesCommercially insured populationColorectal cancerColorectal cancer screening ratesImpact of COVID-19Burden of colorectal cancerColorectal cancer incidenceCancer health disparitiesCRC-related mortalityNeighborhood socioeconomic statusSocioeconomic status quintileSocial deprivation indexSocioeconomic status areasNon-Hispanic blacksNon-urgent careSocially deprived areasEthnic minoritized populations
2019
Underutilization of guideline‐recommended supportive care among older adults with multiple myeloma in the United States
Giri S, Zhu W, Wang R, Zeidan A, Podoltsev N, Gore SD, Neparidze N, Ma X, Gross CP, Davidoff AJ, Huntington SF. Underutilization of guideline‐recommended supportive care among older adults with multiple myeloma in the United States. Cancer 2019, 125: 4084-4095. PMID: 31381151, DOI: 10.1002/cncr.32428.Peer-Reviewed Original ResearchConceptsBone-modifying drugsSupportive careMultiple myelomaInfluenza vaccinationAntiviral prophylaxisOlder adultsLower oddsEnd Results-Medicare databaseNon-Hispanic black patientsMultivariable logistic regression modelBaseline renal impairmentSupportive care useTreatment-related toxicityFacility-level characteristicsNon-Hispanic blacksOutcomes of interestCommunity-based settingsLogistic regression modelsRenal impairmentActive treatmentBlack patientsCare useConcomitant useProphylactic antiviralsReduced odds